If approved, enfortumab vedotin with KEYTRUDA would be the first combination in China to offer an alternative to chemotherapy
Mungara has over 25+ years of experience in the supply chain domain
Pivotal trial found the enfortumab vedotin plus pembrolizumab combination significantly extended overall and progression-free survival
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
The new ECO grade is made using renewable feedstock
Lack of technology transfer stands out as a formidable barrier
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
Subscribe To Our Newsletter & Stay Updated
